金融公司在报告季度收入增长24.7%后,提振了辉瑞的股份。 Financial firms boost holdings in Pfizer after it reported a 24.7% rise in quarterly revenue.

Slagle Financial LLC和Austal Financial Partners Inc.增加了其在辉瑞公司的股份,反映出对生物制药公司的信心日益增强。 Slagle Financial LLC and Ausdal Financial Partners Inc. have increased their holdings in Pfizer Inc., reflecting growing confidence in the biopharmaceutical company. 辉瑞公司报告说,季度收入增加24.7%,收入预期低于预期,EPS为0.63美元,预测为4.48美元。 Pfizer reported a 24.7% rise in quarterly revenue and beat earnings expectations, with EPS of $0.63 compared to forecasts of $0.48. 该公司的股票被评为“Moderate Buy”,目标价格为31.92美元,其市场上限达到1年最高水平,为1420.8亿美元。 The company's stock is rated "Moderate Buy" with a target price of $31.92, and its market cap reached a 1-year high of $142.08 billion.